Document Detail


Maternal hypertension and progeny blood pressure: role of aldosterone and 11beta-HSD.
MedLine Citation:
PMID:  10373218     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Epidemiological and experimental evidence suggests that gestational events modulate the level of blood pressure that will be "normal" for the individual as an adult. Glucocorticoid excess during gestation is associated with low birth weight, a large placenta, and adult hypertension in humans and animals. It has been proposed that the deficiency in placental 11beta-hydroxysteroid dehydrogenase activity in humans produces a gestational hormonal milieu, notwithstanding normal circulating levels of glucocorticoids, that predisposes the adult progeny to hypertension. Animal studies indicate that maternal hypertension, excess glucocorticoids, and hydroxysteroid dehydrogenase inhibition program adult blood pressure. Blood pressures of Sprague-Dawley rat dams were manipulated during gestation with continuous intracerebroventricular infusions of vehicle, aldosterone, 11alpha-hydroxyprogesterone, or carbenoxolone at doses known to produce hypertension with no renal effects or with subcutaneous infusions of larger, equally hypertensinogenic doses that produce systemic effects. Blood pressures of all treated dams were significantly greater (P<0.01) during gestation than those of the vehicle ICV control rats but not significantly different from each other. The blood pressures of both male and female progeny (n>/=6 per group, comprising representatives from at least 4 litters) were measured after 6 weeks of age. No significant difference was found in the blood pressure of the pups regardless of the maternal gestational blood pressure or treatment with an enzyme inhibitor, even after high-salt diet challenge.
Authors:
E P Gomez-Sanchez; C E Gomez-Sanchez
Related Documents :
16024828 - Fluid overload contributing to heart failure.
18250558 - Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal ...
11154148 - Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineraloc...
7565468 - Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angioten...
18607168 - The association of elasticity indexes of ascending aorta and the presence and the sever...
1267358 - Membrane ventilating tube for the middle ear.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Hypertension     Volume:  33     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-07-09     Completed Date:  1999-07-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1369-73     Citation Subset:  IM    
Affiliation:
Research Service, Harry S. Truman Memorial Veterans Hospital, Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Missouri-Columbia, Columbia, MO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
11-beta-Hydroxysteroid Dehydrogenases
Adult
Aldosterone / administration & dosage,  pharmacology,  physiology*
Animals
Blood Pressure / drug effects,  genetics*,  physiology
Cerebral Ventricles / drug effects,  physiology
Female
Genomic Imprinting
Gestational Age
Humans
Hydroxyprogesterones / administration & dosage,  pharmacology
Hydroxysteroid Dehydrogenases / metabolism*
Hypertension / genetics*
Infusions, Parenteral
Male
Pregnancy
Prenatal Exposure Delayed Effects
Rats
Sex Characteristics
Chemical
Reg. No./Substance:
0/Hydroxyprogesterones; 312-90-3/11-hydroxyprogesterone; 52-39-1/Aldosterone; EC 1.1.-/Hydroxysteroid Dehydrogenases; EC 1.1.1.146/11-beta-Hydroxysteroid Dehydrogenases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cortisol effects on body mass, blood pressure, and cholesterol in the general population.
Next Document:  Angiotensin-converting enzyme inhibition restores hepatocyte growth factor production in patients wi...